8-K filing — SOLESENCE, INC. (SLSN)
Filed: 2026-10-05 AccNo: 0001171843-26-006412 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-10-05 AccNo: 0001171843-26-006412 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Solesence (NASDAQ:SLSN) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data
Solesence (NASDAQ:SLSN) reported $15.332 million in sales this quarter. This is a 24.69 percent decrease over sales of $20.359 million the same period last year.